|
Carbohydrate/polysaccharide antigens
|
Protein antigen: recombinant/inactivated/conjugated**
|
Live/attenuated organisms
|
|
Pneumococcal polysaccharide (PPSV-23, for example, Pneumovax®)
|
Tetanus, diphtheria, acellular pertussis (TD/DT, TDAP, DTAP)
|
Varicella (VZV, Varivax®, Varilrix®)
|
|
Meningococcal polysaccharide (MPSV-4)
|
Hepatitis A, hepatitis B
|
Shingles, zoster (for example, Zostavax®)
|
|
Typhoid polysaccharide (Vi injection)
|
Seasonal influenza A/B injection
|
Intranasal influenza (for example, Flu-mist®)
|
|
Pandemic influenza (H1N1) injection
| |
|
Human papilloma virus
|
Measles, mumps, rubella
|
|
Anthrax (acellular)
|
Yellow fever
|
|
Inactivated polio (IPV, Salk, IM/SQ)
|
Oral polio (OPV)
|
|
Oral cholera (killed cells)
|
Typhoid (Ty21a oral)
|
|
Pneumococcal conjugate** (PCV-7, PCV-13, for example, Prevnar®)
|
Vaccinia (smallpox)
|
|
Meningococcal conjugate** (MCV-4, <55 years old)
|
Bacillus Calmette-Guérin
|
|
Haemophilus influenza type B protein polysaccharide conjugate** (HiB, PRP)
|
Rotavirus
|
|
Anthrax (live spore)
|
|
Smallpox
|
